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While a great deal is known about the refolding and assembly of purified proteins 
in vitro, there is much less information available on how complex proteins attain their 
final conformation within the cells of higher organisms (1). Immunoglobulins provide 
an excellent subject for such a  study since: (a) they are multichain molecules which 
have  been well characterized physically and  chemically; (b)  the  constituent heavy 
(H) 1 and light (L) polypeptide chains of the fully assembled immunoglobulin G (IgG) 
molecule are covalently linked and IgG can  therefore be easily separated from un- 
assembled and partially assembled precursors; (c) the more than twofold difference in 
size between the H  and L chains makes their separation and identification relatively 
simple; (d) mouse myeloma tumors provide homogeneous populations of cells produc- 
ing large quantities of IgG so that its synthesis and assembly can be readily studied 
using radioactive precursors;  (e)  many different tumors,  some of which are blocked 
in assembly, can be compared (2). 
In the studies which follow, we have examined the synthesis, assembly, and 
secretion of the three major subclasses  2 of mouse  IgG in  14 myeloma tumors 
and two cultured myeloma celt lines. The  tumors and cell lines differed from 
each other in the details of synthesis, assembly, and secretion of IgG, although 
their average behavior resembled closely these  processes in  normal lymphoid 
cells. Both the covalent and noncovalent assembly of fully assembled immuno- 
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globulin  (H2L2)  occurred for the most part  after release of the nascent  H  and 
L  chains  from  the polyribosomes.  The newly synthesized  and  released  chains 
formed  an  intracellular  pool  from  which  the  IgG  molecule  was  assembled 
through  a  series  of  intermediates.  In  each  myeloma,  assembly  occurred  via 
one  major  and  one  or  more  minor  pathways.  The  major  pathway  in  the  as- 
sembly of IgG2a and IgG1 differed from that of IgG2b. The kinetics of assembly 
varied  in  the  different  myelomas  and  required  between  10  and  30  rain  for 
completion. 
Materials and Methods 
Mydoma  Tumors and Cell Lines.--The MPC-11 tumor was provided by Dr. John Fahey 
of the National Institutes of Health. The remaining tumors were induced by us except for 
the SQPC  11  tumor which was induced  by Dr. Paul Anderson.  The subclass  of the para- 
proteins produced by each tumor was determined by double diffusion in agar. All of the tumors 
were of BALB/c origin except the MOPC 245 and MOPC 282 tumors, which were induced in 
mice of an introgressive backcross of the C57BL heavy chain gene cluster onto BALB/c (3). 
MOPC 245 arose in a third backcross mouse. The original host was heterozygous for C57BL 
and BALB/c heavy chain genes and the myeloma protein was shown by electrophoresis to be 
directed by the C57BL IgG1  (F 8) heavy chain gene  (3). The MOPC  282  tumor arose in a 
seventh backcross mouse that was homozygous for BALB/c genes. Both tumors have been 
successfully~ serially transferred in BALB/c mice. All of the tumors were maintained by sub- 
cutaneous passage in BALB/c mice. 
The MPC-11  cell line was adapted  to continuous culture in this laboratory and has been 
described in detail elsewhere  (4, 5). The P3 cell line was originally adapted to culture from the 
MOPC 21 tumor by Dr. Horibata at the Salk Institute, and has been described in detail by 
Schubert (6). This cell line was kindly provided by Dr. Corrado Baglioni of the Massachusetts 
Institute of Technology. The cell lines were maintained in Dulbecco's modified Eagle's me- 
dium (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 20% horse serum 
and nonessential amino acids. 
Immunization  of Normal Mice.--BALB/c mice were immunized in the hind footpads with 1 
mg of hemocyanin suspended in 0.1  ml of pertussis vaccine (Eli Lilly & Co., Indianapolis, 
Ind.)  (7). This mixture was reinjected at 6 wk, and 1 wk later the popliteal lymph nodes were 
removed and examined as described below. Under these conditions, no IgM was synthesized 
at the time of analysis. 
Incubation of Cells with Radioactive Precursors:--Single  cell suspensions  were prepared from 
tumor fragments and from popliteal lymph nodes as described previously (4,  5),  and were 
suspended in Eagle's spinner medium  (8)  containing 1/20th the normal amounts of valine, 
threonine, and leucine. In the continuous labeling experiments, 15  )<  106 cells in 3 ml were 
incubated at 37°C with 3 #Ci each of L-valine-liC, threonine-14C, and leucine-14C  (uniformly 
labeled, specific activity >  0.15 Ci/mmole, New England Nuclear Corp., Boston, Mass.). 2 ml 
of the cell suspension was removed after 15 min, chilled, and cytoplasmic lysates were prepared 
as outlined below. Secreted material was prepared  after a  3 hr incubation from the super- 
natant medium of the remaining 5 X  106 cells. In the pulse-chase experiments, 30 X  108 cells in 
3 ml were incubated at 37°C with 20 #Ci each of L-valine-laC, threonine-lac, and leucine-14C. 
As has been described previously (5), after 2.5 rain, the cells were chased by the addition of 3 ml 
of medium containing 20 times the normal amounts of valine, threonine, and leucine. 1 ml of 
cell suspension containing 5 X  106 cells was removed at varying intervals after the chase, the 
cells were chilled, and  cytoplasmic lysates were prepared.  There was never any increase in 
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Preparation of Cytoplasmic Lysates and Immunological Predpitation  of the Immunoglobulin 
Molecules.--The labeled cells were pelleted by centrifugation at 1000 rpm for 5 min, and the 
pellets were resuspended in an isotonic buffer as previously described  (4,  5). The detergent 
Nonidet P-40  (Shell Chemical Co., New York) was added to a  final concentration of 0.5%, 
and iodoacetamide was added to a final concentration of 0.1 M to prevent disulfide interchange 
(4,  5).  The nuclei and ribosomes were removed by sedimentation at 105,000  g for 30 rain at 
4°C. One-half of each cytoplasmic lysate was treated with 2% sodium dodecyl sulfate (SDS) 
for 1 min at 100°C. The remaining half was precipitated with an excess of rabbit antiserum 
to mouse immunoglobulin. All incubations were carried out for 16 hr at 4°C.  The immune 
precipitates were washed and dissolved in 0.01 ~  sodium phosphate buffer (pH 7.0) containing 
20-/o SDS by heating at 100°C for 1 rain. Iodoacetamlde was added to a final concentration of 
0.15. 
Preparation of Antiserum.--Antiserum  reactive with both mouse "yFI and kappa L  chains 
was prepared by immunizing rabbits with purified MPC-11 paraprotein and then boosting 
with completely S-carboxyrnethylated 1VIPC-11 protein. Antiserum specific for "yH chains was 
obtained by immunizing rabbits with purified Fc fragments. Antiserum reactive with kappa 
L  chains but not with "yH chains was prepared by immunizing rabbits with the purified IgA 
paraprotein produced by the Adj. PC 6A tumor (3). This antiserum reacts with L  chains in 
combination with both "y and c~ heavy chains. 
Acrylamide Gel Analysis  of Labded Proteins.--Cytoplasmic  lysates, secreted material, and 
immunological precipitates were  analyzed  on SDS-containing acrylamide gels as described 
previously  (4,  5). This technique separates immunoglobulin molecules on the basis of their 
size (9). The gels were fractionated mechanically as described by Maizel (10) and the samples 
were  collected  on planchettes and  counted  in  a  Nuclear-Chicago low  background counter 
(Nuclear-Chlcago Corporation, Des Plaines, Ill.). 
RESULTS 
Production  of IgG.--The  synthesis and  secretion of the  three major  sub- 
classes  of mouse IgG has been examined using cells from 14 different tumors, 
two cell lines, and from the popliteal lymph nodes of immunized mice. The 
results with one tumor from each subclass are shown in Fig. 1. Cell suspensions 
were incubated with radioactive amino acids for 15 rain and the labeled soluble 
cytoplasmic proteins were analyzed on SDS-containing acrylamide gels  (top 
panels, Fig. 1). The cytoplasm of each of the three tumors contained a number 
of distinct radioactive peaks superimposed on a  diffuse background of labeled 
cell protein.  The  labeled irnmunoglobulin molecules were  identified by pre- 
cipitating the cytoplasmic lysates with antiserum reactive with "yH and kappa 
L  chains and then analyzing the precipitates  on SDS-containing acrylamide 
gels (middle panels, Fig. 1). The polypeptide composition of each of the immu- 
noglobulin peaks was established by: (a)  calculating their molecular weights 
(4,  9)  based on their migration in SDS acrylamide gels (4,  9),  and (b)  by re- 
covering the protein in each peak and determining the relative content of H 
and L chains after reduction and alkylation (4). Based on these determinations, 
a  continuum of immunoglobulin intermediates was identified within the cells. 
The immunoglobulin molecules secreted into the culture fluid during a  3  hr 
incubation  with  radioactive  precursors  were  also  examined  (bottom  panels, R.  BAUMAL,  l~.  POTTER,  AND  M.  D.  SCHARF:F  1319 
Fig.  1).  Although  the  immunological  precipitates  of  the  secretions  are  not 
shown,  all  of the  peaks  could be precipitated  with  specific  antiserum  (4).  A 
similar  analysis  was  performed  using  the  cells  obtained  from  the  popliteal 
lymph nodes of immunized BALB/c mice (Fig. 2). 
Since SDS disrupts noncovalent bonds but has no effect on disulfide bonds, 
analysis in the presence of SDS does not necesarily reveal the true composition 
of all of the immunoglobulin molecules. Nevertheless,  it can be concluded that 
LPC- ]  jig G2a }  MOPC195  (Ig G 2b)  MOPC 245 (loG1)  ~F  ~  ¢¥TORL~S~ 
~D  I  [  ',  i  I  I 
m  SECRETION  24 
E  I 
SECRETION  SECRETION 
10  20  30  40  50  60  70  10  20  30  40  50  60  70  10  20  30  40  50  60  7Lo 
FRACTION  NUMBER  FRACTION  NUMBER  FRACTION  NUMBER 
FIG.  1.  Production of the three subclasses of IgG by mouse myeloma tumors. Cell suspen- 
sions were prepared from each of the three myeloma tumors shown. The cells were incubated 
with  amino acids-14C and labeled cytoplasm, immunologically precipitated  cytoplasm, and 
secretion were prepared  as  described in the Materials  and  Methods.  These  samples were 
analyzed by electrophoresis on 5% 20-cm SDS-acrylamide gels for 16 hr at 70 v. The gels were 
fractionated into planchettes and the radioactivity in each of the planchettes was determined. 
The direction of migration on the above and on all subsequent electropherograms is from left 
to right. 
each of the three tumors depicted in Fig. 1 differs from the others in the relative 
amounts  of immunoglobulin  and  cell  protein  produced,  and  in  the  relative 
amounts of partially assembled or unassembled molecules present intracellularly 
and  secreted.  The  characteristics  of  each  of  the  tumors  examined  are  sum- 
marized  in  Table  I.  There  was  considerable  individual  variation  and  each 
tumor  appeared  to  have  distinctive  patterns  of immunoglobulin  production 
which was reproducible. All of the tumors produced large amounts of immuno- 
globulins and contained significant amounts of the various partially assembled 
or  unassembled  molecules.  In  addition,  all  of  the  tumors  secreted  some  in- 
completely  assembled  molecules.  These  findings  could  not  be  ascribed  to 1320  SYNTHESIS,  ASSEMBLY,  SECRETION  OF  "/-GLOBULIN.  III 
cellular  heterogeneity  since  a  number  of  spleen  clones  of  the  MPC-11  and 
MOPC  173  tumors were identical with their parent tumors in  their patterns 
of IgG production  (4,  11). The presence of the partially assembled molecules 
seen in Fig.  1 and Table I  was not because of abnormal metabolic conditions 
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FIO.  2.  Production of IgG by lymphoid cells of hyperimmunized mice. An isolated cel 
suspension was prepared from the popliteal lymph nodes of hyperimmunized mice. The cells 
were incubated with amino acidsJ4C  and labeled cytoplasm,  immunologicaUy precipitated 
cytoplasm, and secretion were prepared  as described in the Materials and Methods. All sam- 
ples were analyzed by electrophoresis on SDS-acrylamide gels, 
during  short-term in  vitro  incubation  of  the  cells  since  similar  results  were 
obtained when  MPC-11  (12),  LPC  1,  and  MOPC  31C,  494,  21A,  173,  were 
labeled in vivo (see below). 
The  IgG2b-producing  tumors  differed from  tumors  of  the  other  two  sub- 
classes in that they all contained more half molecule (HL) intracellularly and, 
as  a  group,  appeared  to secrete more free L  chains  (Table I). However,  the 
production  of excess L  chains  cannot be reliably evaluated by examining se- R.  BAUMAL,  M.  POTTER,  AND  ~f.  D.  SCHARFF  1321 
TABLE  I 
Characteristics of IgG  Production by  Mouse  Myeloma  Tumors,  Cultured Myeloma  Cell Lines, and 
Normal  Lymphoid  Cells 
%  Ira-  Intracellular immunoglobulin  Secreted immunoglobulln 
muno- 
globulin  H~L~  H2L  H~  HL  Hq-L~  L  H~L2  H2L  H~  HI,  H-bL2  L 
Immune lymph node  30  45  10  10  5  10  20  75  9  4  0  5  7 
IgG myelomas (average)  29  41  13  11  8  4  23  76  7  2  4  3  8 
I.  IgGsa 
Adj. PC-5  29  32  24  22  3  3  16  91  8  1  0  0  0 
MOPC 494  36  38  21  10  4  6  21  82  7  2  2  2  5 
MOPC 173  15  35  17  8  4  2  32  90  10  0  0  0  0 
LPC 1  32  27  22  21  2  1  27  80  8  2  2  4  4 
IX.  IgGzb 
MOPC 282  21  54  6  4  14  2  20  80  3  1  0  4  12 
MOPC 195  21  41  7  10  20  6  16  57  17  1  8  1  16 
TEPC 129  38  20  7  19  16  4  34  50  8  1  4  8  31 
tumor  30  25  3  4  21  13  34  36  2  2  28  4  28 
/ 
MPC 11 \ 
culture  25  46  10  9  7  13  15  80  2  0  4  6  8 
SQPC 11  40  50  12  6  15  5  12  70  14  3  6  2  5 
MOPC 141  28  33  16  4  16  9  22  70  14  4  8  3  I 
III. IgGt 
MOPC 245  43  49  11  8  2  3  27  84  7  2  0  1  6 
MOPC 160  23  53  9  2  0  2  34  71  4  3  1  7  12 
MOPC 31C  31  37  20  25  2  2  14  91  4  2  0  1  2 
tumor  30  49  7  19  2  4  19  92  6  2  0  0  0 
/ 
MOPC 21A 
\ 
culture  24  61  10  6  3  2  18  96  0  3  0  3  1 
Cell suspensions were prepared from each of the mouse myeloma tumors listed and from the popliteal lymph nodes of 
hyperimmunized mice. These cells and the cultured myeloma cell lines were incubated with amino acids-14C  and labeled 
cytoplasm, immunologically  precipitated cytoplasm~ and secretion were prepared as described in the Materials and Meth- 
ods. The per cent immunoglobulin  was estimated by planirnetry from the gels of the cytoplasmic lysates. The area under 
the imrnunoglobulin  peaks was measured and expressed as a percentage of the area of the total labeled cell protein. The 
values so obtained were in close agreement with those derived by specifically precipitating an aliquot of cytoplasm lysate 
and expressing the trichloroacetie acid (TCA)-precipitable counts in the immunological  precipitate as a percentage of the 
total cytoplasmic TCA-precipitable counts. The radioactivity in all the peaks on the gels of the immunologically pre- 
cipitated cytoplasm and secretion was calculated and the amount of intracellular and secreted immunoglobulin  molecules 
in each peak was expressed as the per cent of total. The identity of the various peaks was established on the basis of 
their molecular weights and relative content of H and L chains as outlined in the Results. It was difficult to separate  the 
H  and Ls peaks on the gels, so that the amount of immunoglobulln  in these peaks is shown together. 
creted  material,  since  some  tumors  such  as  MOPC  21  (6)  and  MOPC  173 
appear to degrade the excess L  chains which they produce. Finally, it was ob- 
served that the average pattern of immunoglobulin production of the 14 tumors 
and  two  cultured  lines  was  similar  to  that  of  the  heterogeneous  lymphoid 
population in the lymph nodes of immunized mice (Table I). 
Pathways and Kinetics of Covalent Assembly of IgGs~.--H and L  chains could 1322  SYNTHESIS,  ASSEMBLY,  SECRETION  O:F  T-GLOBULIN.  III 
be assembled into H2Le through a  number of distinct pathways (Table II). In 
order to determine the sequence of formation of the interchain disulfide bonds 
in each of four IgG2~-producing tumors,  pulse-chase experiments were carried 
out. The intracellular immunoglobulin molecules present at various times after 
the chase were examined by electrophoresis of immunologic precipitates. The 
TABLE  II 
Possible Pathways  of Assembly  of  the IgG Molecule 
1  2  3  4  5 
H+H-*H2  H+L~HL  H+L---*HL  H+L  *HL  L+L~L2 
H2 +  L -* H2L  HL +  HL *  HeL2  HL +  H  --* H~L  HL +  L  --* HL2  L2 +  H  --~ HL2 
H2L +  L  -~ H2L~  H2L +  L  -, H2L~  HL2 +  H  --* H2L2  HL2 +  H  --* H2L~ 
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Fla. 3.  Pathways and kinetics of covalent assembly of IgO2a in the LPC  1 tumor. A 
cell suspension was prepared from the LPC  1 tumor. The cells were incubated with amino 
acids-14C for 2.5 rain, chased by adding a 200-fold excess of unlabeled amino acids, and cyto- 
plasmic lysates were prepared and immunologically precipitated as described in the Materials 
and Methods. Gel electropherograms are shown on the left for the samples obtained 5 and 18 
rain after addition of label. On the right, the radioactivity in each peak on the gel electro- 
pherograms was tabulated for all of the samples obtained. 
results with  the LPC  1  tumor  are presented in Fig. 3.  The gel electrophero- 
grams at an early and late time after the chase are shown in the left-hand panel, 
while the results of all the time points are summarized in the right-hand panel. 
In  these  experiments,  the  ribosomes had  been  removed  so  that  only the as- 
sembly of released polypeptide chains was examined. However, since previous 
studies  have  shown  that  all  of  the  nascent  peptides  are  released  from  the 
polyribosomes within 2 rain after the chase (4, 13), it can reasonably be assumed R.  BAIYM.AL~ M.  POTTER~  AND  ~.  D.  SCHARFF  1323 
TABLE III 
Kinetics of Formation of IgG by Mouse Myeloma  Tumors,  Cultured  Cell  Lines, and 
Normal Lymphoid  Cells 
Intracellular 
7 min  18 rain 
Immune lymph node  29  71 
IgG myelomas (average)  49  78 
I.  IgG2, 
Adj. PC-5  33  56 
MOPC 494  50  80 
MOPC  173  52  74 
LPC 1  20  40 
II.  IgG2b 
MOPC 282  63  85 
MOPC 195  58  I00 
TEPC 129  50  80 
tumor  72  100 
/ 
MPC 11 
"\ 
culture  70  83 
SQPC 11  60  83 
MOPC  141  47  91 
III.  IgGx 
MOPC 245  51  81 
MOPC  160  51  86 
MOPC 31C  11  39 
tumor  48  80 
/ 
MOPC 21A 
\ 
culture  52  82 
Pulse-chase experiments were performed in short-term culture with normal lymph 
node cells and the myeloma tumors and cultured cell lines, as described in the Ma- 
terials and Methods. The radioactivity in all the immunoglobuliu peaks on the gel 
electropherograms obtained  at 7 and 18 rain after the addition  of label was calculated.  The 
intracellular  H2L2 present at 7 and 18 min is expressed as the per cent of total radioactivity, 
corrected  by a  factor  obtained  from Table I, showing the percentage  of H2L2 which was 
ultimately secreted at 3 hr. 
that nascent chains play no role in immunoglobulin assembly which occurs later 
than 4.5 min. As in previous studies with the MPC-11  tumor (5),  experiments 
have shown that no immunoglobulin molecules were lost in the nuclear pellet, 
that  the  amount  of  antiserum  used  precipitated  all  of  the  immunoglobulin 1324  SYNTHESIS,  ASSEMBLY,  SECRETION  OF  7-GLOBULIN.  III 
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molecules, and that similar results are obtained without immunological precipi- 
tation. 
In the LPC 1 tumor,  the major intermediates  in the assembly of H2L2 were 
heavy chain dimer  (H2)  and H2L (Fig. 3). Immediately after the chase,  there 
were large amounts of H2 present. As this molecule decreased in amount there 
was a  progressive increase  and then  decrease in H2L, followed in time by an 
increase  in  H2L2.  This  suggested  that  pathway  1  (Table  II)  was  the  major 
pathway of assembly of IgG2~ in this tumor. Since there was a small amount of 
HL  present  which  was  assembled  into  H2L2,  pathway  2  and/or  3  was  also 
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FIG. 4.  Covalent and noncovalent assembly of IgG2a in the Adj. PC-5 tumor. A pulse- 
chase experiment was performed on the Adj. PC-5 tumor as described in the Materials  and 
Methods and in Fig. 3. One-third of the cytoplasmic lysates obtained at 4 and 18 rain after 
the addition of label was precipitated  with (a) antiserum reactive with mouse 7H and kappa 
L chains (Fig. 4 A); (b) antiserum reactive with mouse kappa L chains (Fig. 4 B); (c) anti- 
serum specific for mouse TH chains (Fig. 4 C). 
operative,  although quantitatively minor. In this and subsequent experiments 
with  other  tumors,  90%  or more of the  radioactivity  present  in  the  various 
intermediates  at 5 min could be accounted for in H2L2 and the intermediates 
remaining at 18 min. Of the H  and L  chains which were ultimately assembled 
into H2L2 in LPC 1, 20% were assembled by 7 min and 40% by 18 min (Table 
HI). 
Three additional IgG2a-producing tumors were analyzed in the same way as 
the LPC  1 tumor.  Although they differed somewhat from one another in the 
details  of the assembly process, all utilized H2 and H2L (pathway  1)  as their 
major  pathway  of assembly,  and  all  contained  small  amounts  of HL which 
were also assembled into H~L~. R.  BALrMAL~  M.  POTTER,  AND  M.  D.  SCHARFF  1325 
Noncovalent Assembly of IgG2a. -The sequence of formation of the interchain 
disulfide bonds need not necessarily reflect the noncovalent associations of the 
polypeptide chains. For example, the free H  chains seen on SDS  acrylamide 
gels could have been associated noncovalently with L chains and H2 could have 
noncovalently linked L  chains attached to it. In order to study noncovalent 
assembly, pulse-chase experiments were carried out and the cytoplasmic lysates 
were precipitated with:  (a)  antiserum  reactive with  both ~,H  and  kappa  L 
chains;  (b)  antiserum reactive with kappa L  chains but not with "IH chains; 
and (c) antiserum specific for H  chains. When the Adj. PC-5 tumor was exam- 
ined at 4 and 18 rain after labeling, the results with antibody against H  and L 
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Fla.  5.  Pathways and kinetics of covalent assembly of IgG1 in the MOPC 31C tumor. A 
pulse-chase experiment was performed  on the MOPC 31C tumor, as described  in the Materials 
and Methods and in Fig. 3. 
chains  (Fig.  4  A)  were  generally similar  to  those  presented for the LPC  1 
tumor (Fig. 3). When the portions of the same lysates were precipitated using 
antibody against L  chains (Fig. 4 B), all of the L  chain-containing molecules 
were precipitated but only negligible  amounts of H  and H~ were identified. 
When antibody specific for H  chains was used (Fig. 4 C), all of the H2 and H 
were precipitated but no free L  chains were detected. These results indicate 
that most of the H  and H2 did not have noncovalently linked L  chains associ- 
ated with them, and strongly suggest that pathway 1 was the major pathway 
of noncovalent as well as of covalent assembly of IgG2~. 
Assembly of IgGz. -The kinetics and pathways of covalent assembly of IgGz 
were examined in four tumors and one cultured cell line. Two of these experi- 
ments are shown in Figs. 5 and 6. MOPC 31 assembled IgGx relatively slowly, 1326  SYNTHESIS,  ASSEMBLY,  SECRETION  OF  "/-GLOBULIN.  III 
while MOPC 245  assembled it much more rapidly (Table III). As with IgG2a, 
H2 and H2L (pathway 1) were the major precursors of H2L2, while HL was a 
minor precursor. The noncovalent assembly of some of these IgG1 tumors was 
examined as described for the LPC 1 tumor with similar results. 
Since all of the foregoing experiments were carried out with tumor cells in 
short-term culture,  it was important to determine whether  similar pathways 
and kinetics of assembly existed in vivo. Mice bearing myeloma tumors were 
injected  intravenously  with  radioactive  amino  acids  and  5  rain  later  they 
received  an  injection  of  unlabeled  amino  acids.  Tumors  were  removed  at 
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FIG. 6.  Pathways and kinetics of covalent assembly of IgG1 in the MOPC 245 tumor. A 
pulse-chase experiment was performed on the MOPC 245 tumor as described in the Materials 
and Methods and in Fig. 3. 
various times after the chase and cytoplasmic lysates were analyzed. In these 
experiments it was difficult to achieve an identical degree of labeling in all mice 
and to be certain of the effectiveness or time of onset of the chase. Nevertheless 
the in vivo results (Fig. 7) were quite comparable to those found in vitro (Fig. 
5). 
Assembly of IgG2b.--As discussed  above,  the initial  characterization  of the 
various tumors (Table I) indicated that, after 15 min of incubation with label, 
the cytoplasm of the six IgG2b-producing tumors and cultured  cell lines con- 
tained larger amounts of I-IL than did any of the tumors of the IgG2a or IgG1 
subclasses. When pulse-chase experiments were performed with IgG2b tumors, 
they were found to differ from the other two subclasses in that HL was a major 
precursor  of H2L2.  Two  examples are  shown  in  Figs.  8  and  9.  Since,  in  all R. BAUMAL,  M. POTTER,  AND  M. D. SCIIARFF  1327 
IgG2b-producing tumors, H2 and H2L were also significant intermediates, it was 
not possible to be certain whether pathway 2, 3, or both (Table II) was opera- 
tive. The  MPC-11  tumor  differed from  the other IgG2b-producing tumors  in 
that it was unable to form a  covalent bond between the HI, precursors. The 
details of its assembly and mechanism of the block have been described pre- 
viously (5).  However,  it is interesting  to  note  that,  in  the  MPC-11  tumor, 
significant amounts of H2L2 were assembled via pathway 1. 
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FIO. 7.  Pathways and kinetics of covalent assembly in vivo of IgGt in the MOPC 31C 
tumor. Mice bearing the MOPC 31C tumor received an intravenous injection of 30/zCi of 
valineJ4C, threonine-14C, and leucine-14C. 5 min later, they were given an intravenous injec- 
tion of 0.25 ml of a 200-fold concentrated solution of these same amino acids and the tumors 
were removed at 5.5 and 12 min after the administration of label. The tumors were immediately 
chilled and cytoplasmic lysates were prepared, immunologically precipitated, and analyzed 
on SDS-acrylamide gels as described in the Materials and Methods. The different scales for 
the gel electropherograms shown resulted from the difficulty in obtaining equal labeling in the 
two mice used for this experiment,  as noted in the text. 
Assembly in Lymph Node Cells.--BALB /c mice were immunized using condi- 
tions  that  would  lead  to  predominantly  IgG  antibody formation.  Popliteal 
lk~nph nodes were removed and pulse-chase experiments were carried out  on 
cell suspensions using the same techniques  as with the myeloma tumors  (Fig. 
10).  H2 and HzL were the major precursors of HzL~, but I-IL was also chased 
into  HzL2.  The  relative amounts  of  the various subclasses vary  enormously 
depending on a  variety of conditions, but IgG1 and IgG2~ are usually present 
in serum in greater amounts  than IgG2b (14). 1328  SYNTHESIS,  ASSEMBLY,  SECRETION  OF  'y-GLOBULIN.  III 
DISCUSSION 
The assembly of the three major subclasses  of mouse IgG has been studied 
in  14 myeloma tumors and two cultured cell lines  and has been compared to 
the assembly of IgG  by popliteal lymph node cells  of hyperimmunized mice. 
In earlier  studies, we (13,  15) and others (6, 16)  have presented  evidence that 
some of  the initial  covalent  and  noncovalent association  of H  and L  chains 
occurs while the H chains are still associated with the polyribosomes. However, 
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FIG. 8.  Pathways and kinetics of covalent assembly of IgG2b in the MOPC 195 tumor. A 
pulse-chase experiment was performed on the MOPC 195 tumor as described in the Materials 
and Methods and in Fig. 3. 
the kinetics of the assembly process described above indicate that most of the 
covalent and noncovalent assembly must occur after release of H  and L  chains 
from the ribosomes. Studies on the MPC-11  (5)  and MOPC  173  (11)  tumors 
have shown that newly released  chains continued to assemble even when the 
remaining nascent chains are frozen on the polyribosomes after treatment with 
cycloheximide.  In  contrast,  the studies  of Schubert  (6)  suggested  that  all  of 
the interchain disulfide bonds were formed in the P, cell line while the newly 
synthesized  chains  were  still  associated  with  the polyribosomes.  In  our  own 
studies with the P3 cultured cell line and with the MOPC 21A tumor from which 
it was derived, we found significant amounts of H, L, I-IL, H2, and H2L in the 
cytoplasm  and  these  intermediates  subsequently  were  assembled  into  H2L2 
(17).  The fact that Schubert did not find intermediates off the polyribosomes R.  BAUMAL~ M.  POTTER~ AND  M.  D.  SCHARFF  1329 
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and Methods and in Fig. 3. 
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may have been because he did not add iodoacetamide to the reaction mixture 
during immunological precipitation so that self assembly could have occurred. 
With  the  exception  of  the  MPC-11  tumor  (13),  we  have not  examined  the 
polyribosomes of the remaining tumors for the presence of assembled nascent 
chains. 
Studies from a  number of laboratories have suggested that  the newly syn- 
thesized H  and L  chains  are released from the polyribosomes into the rough 
endoplasmic reticulum and then are transported to the outside of the cell via 
the Golgi apparatus, smooth endoplasmic reticulum, and perhaps some sort of 
secretory vacuole (19-22). The postribosomal assembly which we have described 
presumably occurs during  the course of intracellular  transport.  Vassalli et al. 
(23) have shown that an intact endoplasnfic reticulum is necessary for assembly 
in a cell-free immunoglobulin synthesizing system. 
The myeloma tumors which we have examined differed from one other in a 
number of ways, including  the rate at which  they assembled their H  and L 
chains into the completed HzL2 molecule (Table III). At 7 Inin,  there was a 
distinct difference between the average kinetics of the H2L2 formation by the 
tumors and cultured cell lines on the one hand,  and the immune lymph node 
cells on the other (Table III). However, almost all of the tumors and cultured 
lines  were relatively efficient in  that  they ultimately assembled most of the 
intermediates  into  H2L2  (Table  I,  secreted  immunoglobulin).  There  were 
exceptions,  however,  such  as  the  MOPC  195  and  MPC-11  tumors,  which 
secreted relatively large amounts  of H2L and  HL,  respectively. Some excess 
free L  chains were synthesized and secreted by most of the tumors, cultured 
lines, and immune lymph node cells. 
Studies on some of the IgG2a and IgG1 tumors suggested that the noncovalent 
association of the H  and L  polypeptide chains occurred over a period of many 
minutes and that the interchain disulfide bonds were formed at about the same 
time as  the  noncovalent  bonds.  We have no  information  on  the  kinetics  of 
folding of the individual chains or the time of formation of the intramolecular 
disulfide bonds. Studies  on the refolding of a  number of different enzymes in 
vitro (24,  25)  have shown that there is an initial rapid (30-60 sec) folding of 
the polypeptide chain followed by a  series of slow relatively minor rearrange- 
ments leading to the final biologically active enzyme. Studies on the association 
of purified rabbit H  and L  chains in vitro have suggested that the native con- 
figuration of the whole molecule can be achieved more readily if the individual 
chains  are allowed to refold before association with  each other  (26,  27).  The 
present experiments show that there is ample time for folding of the individual 
chains to occur before final assembly. 
Perhaps the most interesting observations made in the present study relate 
to  the  pathways  of  assembly  of  the  IgG molecule.  Each  tumor  assembled 
IgG through  one major and  one or more minor pathways.  As noted  above 
neither cellular heterogeneity nor abnormal metabolic conditions could account R.  BAUMAL,  M.  POTTER,  AND M.  D.  SCItARF~F  1331 
for these findings. Two, and perhaps three, of the theoretical pathways (Table 
II) were observed. Pathways 4 and 5 (Table II), involving light chain dimer 
(L~) as an intermediate, do not appear to occur since: (a) L2 is not present in 
large amounts in any of the IgG tumors; and (b) when L~ was present, as in 
MPC-11 (4), it was an end product since it did not chase into H2L2, 
The tumors producing IgG2~ and IgG1 utilized H2 and HzL (pathway 1) for 
both  covalent  and  noncovalent  assembly  of  the  immunoglobulin molecule 
(Fig. 4). The tumors producing IgG2b utilized HL preferentially (pathway 2 
or 3) as the major precursor in the covalent assembly of HzL2 (Figs. 8 and 9). 
In a  previous study with the MPC-11  tumor, it was demonstrated that two 
HI, were associated by noncovalent interaction, although there was a block in 
the formation of the inter-H chain disulfide bonds (5). Therefore, at least in 
this IgG2b-producing tumor, noncovalent assembly also proceeded via path- 
ways 2 and/or 3. 
Askonas and Williamson have shown that in an additional IgG2a-producing 
tumor, 5563, H2 and H~L were also the major precursors of HzL2 (28).  Suther- 
land et al. (29) have also shown that the major precursors of the IgG2a protein 
produced by the Adj. PC-5 tumor were H, H2, and H~L. Hanaoka reported that 
HL was a major precursor of HzL~ in a cell line derived from MOPC 31B (30). 
Our own studies with the MOPC 31C tumor (Fig. 5)  indicated that H2 and 
H2L but not HL were the major precursors of HzL2. This discrepancy could 
reflect the difference in the cells previously noted (2). The importance of HL 
as a precursor of IgG2b presumably reflects some property of the H chain. This 
subgroup specificity in pathways of assembly is not correlated with the location 
of the inter H-L disulfide bond which appears to be similar for IgG2a and IgG2b 
and different of IgG1  (31),  or with the structural differences related  to the 
ability to fix C', since both IgG2a and IgG2b fix complement while IgG1 does 
not (32). 
Although assembly of the immunoglobulin molecule has not been studied as 
extensively in other species, HL has been shown to be a precursor in one human 
IgG  myeloma (33),  in  a  number  of IgM  macroglobulinemias  (34),  and  in 
normal rabbit IgG (29). Continuous human lymphoid cell lines secreting human 
IgG use H2  and HzL as major intermediates (35).  Additional studies using 
human cells will be necessary to determine if the subgroups of IgG assemble 
through different pathways. 
Finally, both H~ and HzL have been shown to be precursors  of HeL2  in 
hyperimmunized lymphoid cells of BALB/c mice, indicating that the pathways 
observed in the tumors are also used in assembly of normal mouse IgG. 
SUMMARY 
The  synthesis,  assembly,  and  secretion  of  the  three  major  subclasses  of 
mouse IgG has been examined in 14 myeloma tumors and two cultured cell 
lines as well as in the cells from the popliteal lymph nodes of immunized mice. 1332  SYNTHESIS~ ASSEMBLY~ SECRETION  OF  ')'-GLOBULIN. III 
The total amount of IgG synthesized was between  15  and 43 %  of the cyto- 
plasmic proteins made during a  15  min period.  H2 and  H2L were  the major 
precursors of IgG2~ and IgG1 but, in all of the tumors, HL was also an inter- 
mediate.  In contrast,  HI, was a  major precursor of IgG2b.  Most of the non- 
covalent  and  covalent  assembly of IgG occurred after  release  of  the  newly 
synthesized H  and L  chains  from  the  polyribosomes and  assembly  was  not 
completed until 10 min or more after the synthesis of the polypeptide chains. 
We wish to thank Mrs. Linda Stern, 1Vfrs. Ellyn Fischberg, Mrs. Elizabeth B. Mushinski, 
and Mr. Alvado  F. Campbell for their expert technical assistance. 
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